BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30667466)

  • 1. Comparison of Clinical Care and In-Hospital Outcomes of Asian American and White Patients With Acute Ischemic Stroke.
    Song S; Liang L; Fonarow GC; Smith EE; Bhatt DL; Matsouaka RA; Xian Y; Schwamm LH; Saver JL
    JAMA Neurol; 2019 Apr; 76(4):430-439. PubMed ID: 30667466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke.
    Boehme AK; Siegler JE; Mullen MT; Albright KC; Lyerly MJ; Monlezun DJ; Jones EM; Tanner R; Gonzales NR; Beasley TM; Grotta JC; Savitz SI; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e255-61. PubMed ID: 24468069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.
    Saver JL; Fonarow GC; Smith EE; Reeves MJ; Grau-Sepulveda MV; Pan W; Olson DM; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2013 Jun; 309(23):2480-8. PubMed ID: 23780461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and ethnic differences in outcomes in older patients with acute ischemic stroke.
    Qian F; Fonarow GC; Smith EE; Xian Y; Pan W; Hannan EL; Shaw BA; Glance LG; Peterson ED; Eapen ZJ; Hernandez AF; Schwamm LH; Bhatt DL
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):284-92. PubMed ID: 23680966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity.
    Johnston SC; Fung LH; Gillum LA; Smith WS; Brass LM; Lichtman JH; Brown AN
    Stroke; 2001 May; 32(5):1061-8. PubMed ID: 11340210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy.
    Restrepo L; Bang OY; Ovbiagele B; Ali L; Kim D; Liebeskind DS; Starkman S; Vinuela F; Duckwiler GR; Jahan R; Saver JL
    Cerebrovasc Dis; 2009; 28(4):384-90. PubMed ID: 19713698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of critical care needs after IV thrombolysis for acute ischemic stroke.
    Faigle R; Sharrief A; Marsh EB; Llinas RH; Urrutia VC
    PLoS One; 2014; 9(2):e88652. PubMed ID: 24533130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and ethnic disparities in the use of intravenous recombinant tissue plasminogen activator and outcomes for acute ischemic stroke.
    Nasr DM; Brinjikji W; Cloft HJ; Rabinstein AA
    J Stroke Cerebrovasc Dis; 2013 Feb; 22(2):154-60. PubMed ID: 22155116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
    Lin CB; Peterson ED; Smith EE; Saver JL; Liang L; Xian Y; Olson DM; Shah BR; Hernandez AF; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):514-22. PubMed ID: 22787065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Wong LY; Ong BK; Chan BP; Teoh HL
    J Stroke Cerebrovasc Dis; 2010; 19(6):424-30. PubMed ID: 20554224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
    J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcomes among patients transferred to a regional comprehensive stroke center for tertiary care.
    Ali SF; Singhal AB; Viswanathan A; Rost NS; Schwamm LH
    Stroke; 2013 Nov; 44(11):3148-53. PubMed ID: 24021682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of care and outcomes for in-hospital ischemic stroke: findings from the National Get With The Guidelines-Stroke.
    Cumbler E; Wald H; Bhatt DL; Cox M; Xian Y; Reeves M; Smith EE; Schwamm L; Fonarow GC
    Stroke; 2014 Jan; 45(1):231-8. PubMed ID: 24253540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community implementation of intravenous thrombolysis for acute ischemic stroke in the 3- to 4.5-hour window.
    Montaño A; Staff I; McCullough LD; Fortunato G
    Am J Emerg Med; 2013 Dec; 31(12):1707-9. PubMed ID: 24060324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
    Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
    J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prestroke dementia is associated with poor outcomes after reperfusion therapy among elderly stroke patients.
    Busl KM; Nogueira RG; Yoo AJ; Hirsch JA; Schwamm LH; Rost NS
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):718-24. PubMed ID: 22182760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.